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Abstract
Inter-individual variation in patterns of DNA methylation at birth can be explained by the influence of environmental,
genetic and stochastic factors. This study investigates the genetic and non-genetic determinants of variation in DNA
methylation in human infants. Given its central role in provision of methyl groups for DNA methylation, this study focuses
on aspects of folate metabolism. Global (LUMA) and gene specific (IGF2, ZNT5, IGFBP3) DNA methylation were quantified in
430 infants by PyrosequencingH. Seven polymorphisms in 6 genes (MTHFR, MTRR, FOLH1, CbS, RFC1, SHMT) involved in
folate absorption and metabolism were analysed in DNA from both infants and mothers. Red blood cell folate and serum
vitamin B12 concentrations were measured as indices of vitamin status. Relationships between DNA methylation patterns
and several covariates viz. sex, gestation length, maternal and infant red cell folate, maternal and infant serum vitamin B12,
maternal age, smoking and genotype were tested. Length of gestation correlated positively with IGF2 methylation
(rho=0.11, p=0.032) and inversely with ZNT5 methylation (rho=20.13, p=0.017). Methylation of the IGFBP3 locus
correlated inversely with infant vitamin B12 concentration (rho=20.16, p=0.007), whilst global DNA methylation correlated
inversely with maternal vitamin B12 concentrations (rho=0.18, p=0.044). Analysis of common genetic variants in folate
pathway genes highlighted several associations including infant MTRR 66G.A genotype with DNA methylation (x
2=8.82,
p=0.003) and maternal MTHFR 677C.T genotype with IGF2 methylation (x
2=2.77, p=0.006). These data support the
hypothesis that both environmental and genetic factors involved in one-carbon metabolism influence DNA methylation in
infants. Specifically, the findings highlight the importance of vitamin B12 status, infant MTRR genotype and maternal MTHFR
genotype, all of which may influence the supply of methyl groups for DNA methylation. In addition, gestational length
appears to be an important determinant of infant DNA methylation patterns.
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Introduction
DNA methylation is an epigenetic modification that plays an
important role in regulation of gene expression [1]. It provides a
potential mechanism through which the genome can ‘capture’ the
effects of environmental exposures and perpetuate their influence
on physiological systems over long time periods [2]. Factors known
to influence methylation patterns throughout the life course
include nutrition, smoking and age [3–5]. Evidence of consider-
able inter-individual variation in DNA methylation has been
documented in adults [6–11] but the degree of inter-individual
variation in DNA methylation in humans at birth, and the factors
that influence these DNA methylation patterns, are poorly
understood. Emerging evidence suggests that ethnicity, parental
age, maternal pregestational BMI and being born small for
gestational age can influence DNA methylation [12–15] but it is
likely that many more factors modulate the infant methylome
including both environmental and genetic components [16,17].
Factors that modulate one-carbon metabolism and so influence
the provision of methyl groups via S-adenosyl methionine (SAM)
for DNA methylation may be particularly important [18]. For
example, status with respect to folate and the other micronutrient
co-factors required for SAM synthesis via one-carbon metabolism
may influence DNA methylation. In intervention studies in adult
women, restricted folate intake resulted in reduced genome-wide
DNA methylation [19,20]. In addition, genome-wide DNA
methylation in cord blood DNA correlated inversely with maternal
plasma homocysteine concentration [21] and more recent data
from the same group revealed an association between methylation
of 289 CpG sites from fetal cord blood DNA with plasma
homocysteine [22]. Finally, reduced methylation at the IGF2
differentially methylated region, H19 DMR, in cord blood DNA
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pregnancy [23], and maternal peripheral blood DNA methylation
at the IGF2 locus was associated with maternal serum vitamin B12
levels [24]. The latter finding suggests a possible influence of
maternal serum vitamin B12 on cord blood DNA methylation [24].
The influence of maternal one-carbon metabolism on methylation
status in the offspring has been well documented in animal models
[25–32] but as yet there are few studies demonstrating the effect of
this maternal factor on infant DNA methylation in humans [33].
Recent studies of the heritability of DNA methylation patterns
support the postulate that genetic factors are important determi-
nants [7,11,34,35]. In a study of adults examined at two time
points more than a decade apart, some individuals lost but others
gained DNA methylation [34] and patterns of change clustered in
families, suggesting that genetic variation can influence methyla-
tion patterns [34]. Variants in genes encoding components of the
one carbon metabolic cycle are likely to be important in
influencing DNA methylation because of their potential influence
on the methyl donor pool. Indeed, there is evidence that a
common variant of the methylenetetrahydrofolate reductase
(MTHFR) gene is associated with perturbed DNA methylation in
a disease-free population [36] and in colorectal cancer [37,38], but
not, apparently, in other cancers [39]. Although one report
suggests that maternal and infant MTHFR 677C.T does not
affect cord blood methylation of the SLC6A4 gene [40], the impact
of this and other one carbon metabolism gene variants on the
establishment of DNA methylation patterns during pregnancy or
in early post-natal life in humans remains largely unknown.
Given the association between DNA methylation patterns and
gene expression, it is plausible that aberrant methylation patterns
at birth may predispose individuals to higher disease risk later in
life via developmental programming [41]. The relationship
between aberrant DNA methylation and cancer is well docu-
mented [42] and provides a paradigm for hypotheses which
propose that epigenetic mechanisms mediate the link between
environmental exposures and health outcomes in later life [2]. A
recent study suggests that DNA methylation patterns at birth are
associated with risk of childhood obesity [43], which has the
potential to increase the likelihood of a wide range of metabolic
and other diseases. As such, there is a need to establish the
determinants of variation in DNA methylation at birth as a basis
for both avoiding the establishment of aberrant methylation
during development and the prediction and prevention of diseases
later in life.
In summary, there is substantial inter-individual variation in
DNA methylation patterns [6–11] that is likely to be explained by
a combination of genetic and environmental exposures and by
stochastic events. To date, little is known about the factors that
determine variation in DNA methylation patterns at birth. The
aims of this study were to investigate genetic and non-genetic
determinants of variation in DNA methylation patterns in new-
born infants and to assess the contribution of maternal factors,
including folate and vitamin B12 concentrations and the genotype
of enzymes involved in the one-carbon metabolism pathway.
Materials and Methods
Study population
Ethical approval to undertake this study was obtained from the
Newcastle and North Tyneside Local Research Ethics Committee
(07/Q0906/5). Written informed consent was obtained from all
participating mothers recruited during pregnancy. Consent was
obtained for use of their own biological samples and those of their
child (including DNA) for epidemiological studies.
A nested cohort study was undertaken within the North
Cumbria Community Genetics Project [44] and included 430
cord blood DNA samples (mean (6 SD) gestation=39.5 (1.4)
weeks) for methylation and genotype analysis. Of these, peripheral
blood DNA samples for genotype analysis were available from 201
mothers. Samples and data from this prospective, unselected,
population-based cohort were collected between 1996 and 2003 at
a single maternity unit in West Cumbria, UK. Mothers were
recruited at their first antenatal appointment when they completed
a health and lifestyle questionnaire and DNA was extracted from
routine antenatal blood samples (mean (SD) gestation=10.6 (4.3)
weeks). Cord blood was collected and delivery details, birth weight,
sex, gestational age, maternal smoking habits and maternal age
were recorded. Maternal and infant red blood cell folate (RCF)
and serum vitamin B12 analyses were conducted on whole blood
prior to DNA extraction. Summary statistics are provided in
Table 1.
Genotype analysis
Seven polymorphisms in 6 genes involved in folate transport
and in one carbon metabolism (MTHFR 677C.T (rs1801133),
MTHFR 1298A.C (rs1801131), MTRR 66G.A (rs1801394),
FOLH1 1561C.T (rs202676), CbS 644 bp ins, RFC1 80G.A
(rs1051266) and SHMT 1420C.T (rs1979277)) were determined
using standard RFLP methods as described elsewhere [45].
Polymorphisms with genotyping success rates less than 90%, with
minor allele frequencies (MAF) less than 5% were removed prior
to analysis. All variants were assessed for Hardy Weinberg
Equilibrium (HWE). Allele and genotype frequencies are shown
in Table S1.
LUMA assay to determine global DNA methylation
The luminometric methylation assay (LUMA) protocol has been
described in detail previously [46]. Briefly, 200 ng of genomic
DNA was digested with EcoRI+MspI or EcoRI+HpaII in two
separate 20 ml volume reactions containing 5 units of each enzyme
(New England Biolabs) with 2 ml Tango buffer (Fermentas) for 4 h
at 37uC. Digests were carried out in triplicate for each sample.
20 ml PyrosequencingH annealing buffer (Qiagen) was then added
to each reaction and the samples were analysed by Pyrosequen-
cingH on a Pyromark
TM MD system. The instrument was
programmed to add dNTPs in the following steps; dATP, a
mixture of dGTP+dCTP, dTTP and finally a mixture of
dGTP+dCTP. Peak heights were calculated using the Pyro-
Table 1. Baseline characteristics of the study population.
Characteristic N Median 25%, 75%
Males, number (%) 222/424 (52%) - -
Gestation, weeks 423 40.0 39.0, 40.0
Infants red cell folate, ngml 430 491.5 399.0, 602.0
Infants B12, pgml 413 323.0 232.0, 445.0
Mothers age at birth, years 326 28.6 23.5, 32.7
Smoked during pregnancy,
number (%)
47/206 (23%) - -
Mothers red cell folate, ngml
{ 197 379.0 298.0, 512.0
Mothers B12, pgml
{ 158 283.0 226.0, 389.0
{Mothers’ red cell folate and B12 concentrations were measured from routine
antenatal blood samples (mean (SD) gestation=10.6 (4.3) weeks).
doi:10.1371/journal.pone.0033290.t001
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TM 1.0 software. The HpaII/EcoRI and MspI/EcoRI ratios
were calculated as (dGTP+dCTP)/dATP for the respective
reactions. The HpaII/MspI, or methylation ratio was defined as
(HpaII/EcoRI)/(MspI/EcoRI). A higher methylation ratio is
indicative of less methylated DNA.
Bisulfite PyrosequencingH for loci-specific DNA
methylation analysis
Bisulfite conversion of DNA was performed using EZ DNA
Methylation Gold
TM kit (Zymo Research) following the manufac-
turer’s protocol. Briefly, 2 mg of genomic DNA was incubated with
CT conversion reagent and incubated at the following tempera-
tures; 98uC for 10 min, 64uC for 2.5 hr, held at 4uC. DNA was
then transferred to a spin column, washed, desulphonated and
purified, finally eluting in a 10 ml volume.
Quantitative bisulfite PyrosequencingH was used to determine
the percentage methylation at individual CpG sites within the
differentially methylated region 0 (DMR0) of IGF2 (NG_008849.1;
6098–6375) and promoters of IGFBP3 (NT_007819.17;
45951336–45951104) and ZNT5 (NT_006713.15; 18983340–
18983714). Briefly, 0.2 mg of bisulfite treated DNA was added as
a template in a PCR reaction using 12.5 ml Hot Star Taq
mastermix (Qiagen), total volume 25 ml. For ZNT5, a nested PCR
was carried out using 4 ml of a larger amplified region of ZNT5. All
primer sequences and PCR conditions are shown in Table S2.
Biotin-labelled PCR products were captured with streptavidin
sepharose beads (GE Healthcare), and made single stranded using
sodium hydroxide denaturation and a PyrosequencingH Vacuum
Prep Tool (Qiagen). Sequencing primers were annealed to the
single stranded PCR product by heating to 80uC, followed by slow
cooling. PyrosequencingH was then carried out on a Pyromark
TM
MD system. Cytosine methylation was quantified using proprie-
tary PyroQ CpG 1.0.6 software. All PCR and PyrosequencingH
reactions were carried out in duplicate.
For each assay, 0% and 100% methylated controls were
prepared by carrying out a flanking PCR reaction for each gene of
interest on genomic DNA to generate an unmethylated control,
followed by in vitro methylation (SssI treatment) of an aliquot of the
PCR product to generate a methylated control (please see Table
S3 for primers and PCR conditions). These controls were used to
rule out any amplification bias of primers for methylated DNA
and to assess assay reproducibility using methods described
previously [47]. All primer sets were found to be unbiased and
assays were reproducible. Zero and 100% methylated controls
were run routinely alongside samples as internal controls. CpG
sites with poor success rates or extreme low/high methylation
measures (mean methylation=0%/100%) across the study
population were removed before analysis.
Vitamin status measurement
Maternal and infant RCF levels and serum vitamin B12 levels
were measured as detailed elsewhere using an Abbott IMx ion
capture assay for RCF and an immunoassay for serum vitamin B12
(Abbott GmBH, Germany) [45,48].
Data analysis
Correlation was assessed across the locus-specific CpG sites
using non-parametric Spearman’s rank correlation and where
correlation between methylation at the CpG sites analysed within
a single gene was at least modest (rho.0.6) mean percentage
methylation values were also included in the analysis. Non-
parametric Kruskal-Wallis and Spearman’s rank correlation were
used to assess associations between methylation levels and
categorical (namely; infant sex, smoking status during pregnancy
and genotype) and continuous exposure variables (namely;
gestation, infant and maternal vitamin B12, infant and maternal
RCF, and mothers age)respectively. For genetic analyses, meth-
ylation levels were initially compared across all three genotypes
(i.e. applying no model). Subsequently, those variants demonstrat-
ing association were investigated further by applying specific
genetic models (i.e. dominant, recessive and additive). Rare
variants (Minor Allele Frequency (MAF) ,15%) were analysed
under a dominant model, in respect of the minor allele, only.
Univariate and multiple linear regression analyses were subse-
quently performed to further examine the significant associations
(e.g. check for confounding, assess relative and combined effect
sizes). In addition to ordinary least squares (OLS) regression,
robust regression was performed due to its ability to withstand
violations of normality, heteroskedasticity and outliers given the
non-parametric nature of methylation distributions and the
moderate sample size available. All analyses were performed in
STATA version 10 (Statacorp, College Station, TX).
Results
Correlation between methylation at CpG sites within the
same gene
Methylation at three CpG sites was measured in the DMR of
IGF2, at 5 CpG sites in the IGFBP3 promoter and at 5 CpG sites in
the ZNT5 promoter. Methylation of individual CpG sites within
each of the IGF2 and IGFBP3 loci were correlated (rho.0.60, data
not shown) therefore mean methylation levels within each of these
two loci were calculated and used for further analysis. ZNT5 CpG
site 1 was not reliably detected in the assay used and CpG site 4
was highly methylated (i.e. median methylation=100%) and
showed little inter-individual variation, so neither were included in
further statistical analysis. Methylation of sites 2, 3 and 5 in the
ZNT5 promoter were not correlated, so these data were included
in the analysis only as separate measures, and not used to calculate
a mean value.
Non-genetic determinants of methylation status
We investigated the impact of maternal and infant non-genetic
factors on infant methylation patterns (Table 2 and Table 3).
Females showed more methylation than males at IGF2 site 2, and
a longer period of gestation was correlated with increased
methylation across the IGF2 region. Conversely, methylation at
site 3 of the ZNT5 locus was negatively correlated with length of
gestation. Infant B12 status was associated inversely with
methylation across the IGFBP3 locus and especially so at site 4,
whereas maternal B12 concentration correlated inversely with
infant global DNA methylation.
Genetic determinants of methylation status
We investigated the impact of maternal and infant genotype on
infant methylation status (Table 3 and Table 4). Those infants
heterozygous for the MTRR 66A variant had increased global
methylation and decreased IGF2 site 2 methylation compared with
both homozygous groups. Of note, however, this SNP did not
conform to HWE across the infant subgroup (S Table 1). Infants
carrying the minor RFC1 80A variant had increased methylation,
following a dominant trend, at both IGFBP3 site 4 and ZNT5 site
2. Infant CbS 644ins had a low MAF so data were tested under a
dominant model only and we found that carriers of the rare
insertion had increased methylation at IGF2 site 2.
Maternal genotype also influenced infant DNA methylation.
The maternal minor MTHFR 677T variant was associated with
Determinants of Infant DNA Methylation
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mean) following an additive model; methylation of the ZNT5 site 3
locus was increased in infants of mothers carrying one or more
copies of the minor MTHFR 1298C allele; infants of mothers
homozygous for the minor MTRR 66A variant had decreased
methylation at the IGFBP3 locus (sites 1, 3 and 5 and mean
methylation at this locus) compared with infants of mothers
carrying the major MTRR 66G allele; the same recessive pattern
was also observed at the ZNT5 site 5 locus. The maternal GCPII/
FOLHI 1561C.T SNP had a low MAF so data were tested under
a dominant model and we observed that the major homozygous
maternal genotype was associated with lower infant methylation at
the IGFBP3 site 2 locus compared with heterozygous and minor
homozygous maternal genotypes.
Individually, genetic and non-genetic predictor variables
contributed ,0.3 to 8% of the variability in infant methylation
levels, as shown by linear regression r
2 values (Table 3). In
addition, effect sizes on methylation were similar for both genetic
and non-genetic factors. Furthermore, none of these univariate
associations were confounded by or demonstrated evidence of
interaction with sex and/or gestational length. Overall, the
combination of genetic and non-genetic predictors accounted for
,8 to 16% of the total variation in infant methylation levels. It
should be noted that, these regression analyses are likely to be
underpowered for a number of reasons (e.g. limited maternal
genotype data, use of mean methylation as the outcome measure,
and non-parametric nature of methylation data), so that the
apparent lack of significance in some models should be treated
with caution.
Discussion
The determinants of DNA methylation patterns, including the
involvement of folate and other micronutrient co-factors involved
in one-carbon metabolism, are the focus of considerable research
interest [4,49]. This may be expected given the central role of
these micronutrients in the generation of SAM - the methyl donor
for DNA methylation. In addition, evidence is emerging that
ageing and a wide range of environmental exposures including
nutrition and smoking [3,10,19,50–57] as well as heritable
components [7,11,34,35] may modulate DNA methylation
patterns throughout the life-course. However, the impact of these
factors, singly and in combination, on inter-individual variation in
DNA methylation patterns at birth is largely unknown.
In this study we examined global and gene specific methylation
patterns in infants in relation to both non-genetic and genetic
factors involved in one carbon metabolism. For this purpose, we
chose 3 genes with contrasting degrees of methylation; IGF2,a n
imprinted locus with mean methylation ,50%, IGFBP3, consti-
tutively methylated at low levels (,5%), and ZNT5, constitutively
methylated at high levels (,90%). We chose to investigate the
IGF2 gene as it is one of the more frequently investigated loci for
DNA methylation demonstrating altered methylation in response
to environmental influences [11,15,23,33]. Furthermore, both
IGF2 and IGFBP3 are members of the IGF system, which is
important for intrauterine growth [58], hence the investigation of
DNA methylation at the IGFBP3 locus. Finally we selected the
ZNT5 gene for analysis as we had previously observed inter-
individual variation in methylation at this locus in DNA from
human colonic mucosal biopsies (Coneyworth, Mathers & Ford,
unpublished data). We observed that both non-genetic and genetic
factors explained between 0.3 and 8% of the inter-individual
variation in both global and gene specific DNA methylation in
infants, with the combination of both factors accounting for up to
16%. We report that increased maternal serum vitamin B12 was
indicative of lower infant global DNA methylation, and that
higher infant serum vitamin B12 concentration was associated with
reduced methylation at IGFBP3 site 4, and across the IGFBP3
locus. Since vitamin B12 is a rate-limiting co-factor for methionine
synthase reductase (MTRR) in the conversion of homocysteine to
methionine, an integral step in methyl group donation, altered
vitamin B12 supply may influence DNA methylation through SAM
availability. Higher vitamin B12 status may result in increased
SAM which would increase the SAM:S-adenosylhomocysteine
(SAM:SAH) ratio and alter the kinetics of methyl group donation.
Moreover, in the current study, variation in both maternal and
infant genotype at the MTRR locus resulted in changes in infant
methylation, providing further evidence that aberrations at this
point of one carbon metabolism might affect the capacity to
methylate DNA (although it is pertinent to state that larger studies
will be required to definitively assess effect the relationship
between the MTRR 66A.G variant and DNA methylation
patterns, given that this SNP was not in Hardy-Weinberg
equilibrium in this study). Although Wettergren et al (2010) [59]
Table 2. Associations between methylation and non-genetic predictors.
Association/Correlation
{
Non-Genetic Variable Methylation Locus N Test Statistic P-Value
Infant Infant
Sex, Males/Females IGF2 Site 2 194/180 4.80 0.029
Gestation IGF2 Mean 392 0.11 0.032
Infants’ B12 IGFBP3 Site 4 292 20.16 0.007
Infants’ B12 IGFBP3 Mean 294 20.12 0.048
Gestation ZNT5 Site 3 311 20.13 0.017
Maternal Infant
Mothers’ B12 Global* 121 0.18* 0.044
{Non-parametric Kruskal-Wallis test for association was performed between methylation and categorical predictor variables. Spearman’s rank correlation was assessed
between methylation and continuous predictor variables.
*A higher methylation ratio is indicative of less methylated DNA therefore the positive correlation reported shows that a higher maternal serum B12 level is associated
with lower genomic DNA methylation.
doi:10.1371/journal.pone.0033290.t002
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Standard regression analysis
Robust
regression analysis Standardised
Model Outcome Predictor N Coef.
Standard
error P-value R
2
Standard
error P-value beta coef.
Univariate Global Infant MTRR
66 G.A*
307 20.035 0.014 0.009 0.022 0.013 0.007 20.148
Univariate Global Maternal B12 121 1.994610
24 1.049610
24 0.060 0.030 1.105610
24 0.074 0.172
Multiple
ł Global Infant MTRR
66 G.A*
117 20.033 0.015 0.026 0.083 0.014 0.018 20.206
Maternal B12 7.620610
25 7.090610
25 0.285 6.280610
25 0.228 0.097
Sex
{ 20.023 0.014 0.111 0.014 0.108 20.146
Gestation 0.002 0.006 0.761 0.007 0.784 0.028
Univariate IGF2 Site 2 Sex 374 0.517 0.481 0.283 0.003 0.483 0.284 0.056
Univariate IGF2 Mean Gestation 392 0.294 0.175 0.093 0.007 0.182 0.106 0.085
Univariate IGF2 Site 3 Infant MTRR
66 G.A*
382 20.706 0.498 0.157 0.005 0.497 0.156 20.076
Univariate IGF2 Site 2 Infant CbS 644ins* 377 1.404 0.643 0.030 0.013 0.623 0.025 0.112
Univariate IGF2 Site 1 Maternal MTHFR
677 C.T
{
154 2.081 0.694 0.003 0.056 0.651 0.002 0.236
Multiple
ł IGF2 Mean Sex
{ 153 0.828 0.636 0.195 0.080 0.661 0.212 0.105
Gestation 0.422 0.272 0.122 0.288 0.144 0.124
Infant MTRR 66 G.A* 20.251 0.636 0.694 0.654 0.702 20.032
Infant CbS 644ins* 20.977 0.890 0.274 1.004 0.332 20.089
Maternal MTHFR
677 C.T
{
1.286 0.478 0.008 0.460 0.006 0.214
Univariate IGFBP3 Site 4 Infant B12 292 20.002 0.001 0.031 0.016 0.001 0.007 20.126
Univariate IGFBP3 Site 4 Infant RFC1 80G.A* 302 0.676 0.380 0.076 0.011 0.319 0.035 0.102
Univariate IGFBP3 Site 2 Maternal GCPII
1561C.T*
121 0.889 0.353 0.013 0.051 0.378 0.020 0.225
Univariate IGFBP3 Site 3 Maternal MTRR 66
G.A
W
117 20.810 0.497 0.106 0.023 0.207 2.000610
24 20.150
Univariate IGFBP3 Mean Maternal MTRR 66
G.A
W
117 20.655 0.570 0.253 0.011 0.283 0.022 20.106
Multiple
ł IGFBP3 Mean Infant B12 104 20.003 0.001 4.000610
24 0.159 0.001 0.001 20.348
Infant RFC1 80G.A* 0.273 0.268 0.311 0.274 0.321 0.099
Maternal GCPII
1561C.T*
0.247 0.272 0.366 0.300 0.411 0.090
Maternal MTRR 66
G.A
W
20.432 0.422 0.309 0.336 0.202 20.096
Sex
{ 20.256 0.242 0.292 0.249 0.306 20.101
Gestation 20.027 0.107 0.801 0.112 0.810 20.024
Univariate ZNT5 Site 3 Gestation 311 21.374 0.635 0.031 0.015 0.635 0.031 20.122
Univariate ZNT5 Site 2 Infant RFC1 80G.A* 314 3.469 1.396 0.014 0.019 1.481 0.020 0.139
Univariate ZNT5 Site 3 Maternal MTHFR
1298A.C*
132 8.290 2.579 0.002 0.074 2.682 0.002 0.271
Univariate ZNT5 Site 5 Maternal MTRR 66
G.A
W
104 218.714 6.105 0.003 0.084 3.410 2.971610
27 20.290
*Dominant models were applied for these SNPs, hence coefficients reflect the difference in methylation level for carriers of the minor allele compared to major allele
homozgyotes (reference group).
{Females were compared to males (reference group).
{Additive models were applied for these SNPs, hence coefficients reflect the difference in methylation level for each additional copy of the minor allele compared to
major allele homozygotes (reference group).
WRecessive models were applied for these SNPs, hence coefficients reflect the difference in methylation level for minor allele homozygotes compared to carriers of the
major allele (reference group).
łReduced numbers in multiple regression models are due to limited maternal genotype data and removal of outliers, consequently, these reduced numbers may in part
account for the lack of significance seen with some predictor variables. Note also that mean methylation levels were utilized for multiple regression modelling despite
not always demonstrating the strongest effect size with individual predictors. Standardised beta coefficients are obtained by first standardizing all variables to have a
mean of 0 and a standard deviation of 1, they denote the increase in methylation for a standard deviation increase in the predictor variables. Multiple regression analysis
was not performed for ZNT5 associations as mean methylation was not considered across this locus.
doi:10.1371/journal.pone.0033290.t003
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hypermethylation in the mucosa of colorectal cancer patients, de
Vogel et al (2009) observed that MLH1 hypermethylation among
female colorectal cancer cases was inversely associated with
carriage of the MTRR 66G.A variant [60]. In the present study,
both vitamin B12 concentrations and variation in the gene involved
in vitamin B12 metabolism were associated with altered DNA
methylation. This observation suggests that further investigation of
the effects of both vitamin B12 and the MTRR 66G.A genotype
on one-carbon metabolism are warranted to understand the effects
of both the vitamin and SNP on DNA methylation. Both
experimentally-based and mathematical modelling-based ap-
proaches could be applied to advance understanding in this area
[61,62] to account for the influence of complex interactions at
multiple nodes within the one - carbon metabolic pathway on the
phenotype of DNA methylation.
As noted above, folate is an important contributor of methyl
groups to one-carbon metabolism and hence a major determinant
of the quantity of SAM available for the methylation of DNA.
Human intervention studies have shown that moderate restrictions
in folate intake reduced genome-wide DNA methylation [19–20].
More recently an observational study found that higher genome-
wide methylation in DNA from colonic mucosa was associated
with higher serum and erythrocyte folate concentrations [53]. We
hypothesised that RCF concentration would correlate positively
with infant genome-wide DNA methylation but we found no
support for this hypothesis in the present study. Previously, Fryer et
al (2009) [21] reported no association between cord serum folate or
maternal folic acid intake and infant LINE-1 DNA methylation
(an index of non-coding genome-wide methylation), but observed
an inverse correlation between LINE-1 methylation and homo-
cysteine concentration in cord blood. Furthermore, methylation
patterns of 289 CpG sites from fetal cord blood DNA were found
to be significantly associated with plasma homocysteine, but not
serum folate concentrations [22], suggesting that homocysteine, a
functional indicator of availability of one-carbon supply for DNA
methylation which is influenced by several micronutrients may be
a better biomarker in this context than folate per se. It is therefore
plausible that, despite the lack of an association between measures
of folate status and DNA methylation in this study, other
micronutrient co-factors in one-carbon metabolism may influence
methyl group donation which is consistent with our observations
relating to vitamin B12.
Genetic variation in the maternal MTHFR gene was associated
with methylation levels at the IGF2 and ZNT5 loci and
demonstrated some of the largest individual effect sizes (,6–
7%). The MTHFR 677C.T and 1298A.C variant were selected
for investigation because they result in elevation of total plasma
homocysteine and lower circulating concentrations of folate [63]
and as such can be used as unconfounded proxies for high
homocysteine/low folate using a Mendelian randomization
approach [64]. Using this approach there was evidence for an
association between maternal homocysteine/folate levels and
DNA methylation in infants in the present study, inconsistent
with the null relationship observed between the blood based
metabolites themselves and DNA methylation. However, the
present study is limited by a modest sample size which may explain
these inconsistencies. The current study was limited to the analysis
of seven polymorphisms and a more comprehensive appraisal of
genetic variation in one-carbon metabolic pathway may uncover
further associations with DNA methylation pattens.
In this study, maternal smoking did not have any discernable
effect on infant DNA methylation. Previously, Breton et al (2009)
[54] reported lower methylation at AluYb8, but not LINE-1
elements, in buccal cell DNA of children exposed to tobacco
smoke prenatally as well as increases in methylation in two genes -
AXL and PTPRO - out of eight loci studied. Furthermore, cord
serum global DNA methylation had an inverse relationship with
serum cotinine levels, indicating genomic hypomethylation in the
infants exposed to smoking in utero [65]. Conversely, Launay et al.
recently reported increased DNA methyltransferase activity,
decreased DNA methylation and increased gene expression of
the monoamine oxidase (MOA-B) gene in smokers, suggesting
bidirectional gene specific effects of smoking on DNA methylation
[66]. The lack of an association between infant DNA methylation
and maternal smoking during pregnancy observed in this study
may be due to a) use of a different measure of global methylation
compared with previous studies and b) the specific target genes
chosen in this study compared with other loci whereas methylation
of other loci may be plastic in response to smoking.
We observed that DNA methylation patterns were influenced
by length of gestation in a gene specific manner; IGF2 methylation
was positively correlated with gestation length whereas this
correlated negatively with ZNT5 methylation. Previous work has
shown that global DNA methylation in the baboon fetus follows a
tissue-specific trajectory during the second half of gestation with
decreased global DNA methylation in the frontal cortex and no
change in the heart during the later stages of pregnancy [67].
Furthermore, it was reported recently that prematurely born
infants had lower global DNA methylation (measured as LINE-1
methylation) in cord blood compared with term infants, suggesting
that changes in fetal DNA methylation are ongoing during late
pregnancy [68]. In a study of effects of maternal characteristics on
methylation of selected genes in umbilical cord genomic DNA,
maternal BMI correlated positively (r=0.41) with methylation of
the peroxisome proliferator-activated receptor-c co-activator 1a
gene (PPARGC1A) but there was no significant relationship
between methylation of this gene and gestational age [14]. To
the best of our knowledge, ours is the first study demonstrating
effects of gestational age on gene-specific DNA methylation in
infant cord blood DNA, offering additional evidence for a role of
gestation length in the determination of DNA methylation patterns
at birth.
In conclusion, the findings of this study are consistent with the
hypothesis that modulation of one-carbon metabolism influences
DNA methylation in the newborn human infant. As this area of
research is still in its infancy, much remains unknown about how
an individual’s DNA methylation profile is established during
development, what factors might influence the fidelity of these
profiles during the life course and, ultimately the consequences of
these altered profiles for long term health and wellbeing. This
study provided an opportunity to appraise the relationship
between maternal genotype and some environmental exposures
on DNA methylation in infants. By measuring both global and site
specific DNA methylation in 3 genes, we have contributed to the
limited existing data concerning infant methylation in response to
genetic and environmental factors. Although a more comprehen-
sive investigation of methylation at other loci throughout the
genome would provide deeper insights into the determinants of
DNA methylation patterns at birth, the findings from this study
underscore the complexity of the relationship between environ-
mental and genetic determinants and DNA methylation status. We
provide evidence that variation in one-carbon metabolism by
environmental and genetic factors, specifically vitamin B12 the
MTRR 66G.A SNP and MTHFR variants can influence infant
methylation. In addition, gestational length appears to be an
important determinant of infant DNA methylation patterns.
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